IRF5 promotes the proliferation of human thyroid cancer cells.

Item

http://www.wikidata.org/entity/Q39364098

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

IRF5 promotes the proliferation of human thyroid cancer cells.

@en

IRF5 promotes the proliferation of human thyroid cancer cells.

@nl

type

Item

label

IRF5 promotes the proliferation of human thyroid cancer cells.

@en

IRF5 promotes the proliferation of human thyroid cancer cells.

@nl

prefLabel

IRF5 promotes the proliferation of human thyroid cancer cells.

@en

IRF5 promotes the proliferation of human thyroid cancer cells.

@nl

P1476

IRF5 promotes the proliferation of human thyroid cancer cells

@en

P2093

Alessandra Aloisi

http://www.w3.org/2001/XMLSchema#string

Annamaria Fidilio

http://www.w3.org/2001/XMLSchema#string

Francesco Frasca

http://www.w3.org/2001/XMLSchema#string

Manuela Fallica

http://www.w3.org/2001/XMLSchema#string

Michele Massimino

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes

On the role of IRF in host defense

Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death

Virus-induced heterodimer formation between IRF-5 and IRF-7 modulates assembly of the IFNA enhanceosome in vivo and transcriptional activity of IFNA genes

Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes

Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection

A CRM1-dependent nuclear export pathway is involved in the regulation of IRF-5 subcellular localization

The interferon regulatory factors 1 and 2 bind to a segment of the human c-myb first intron: possible role in the regulation of c-myb expression.

Anaplastic thyroid carcinoma: current diagnosis and treatment.

Minireview: branded from the start-distinct oncogenic initiating events may determine tumor fate in the thyroid.

P2888

1476-4598-11-21

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-4598-11-21

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paolo Vigneri

Livia Manzella

P577

2012-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224051256

http://www.w3.org/2001/XMLSchema#string

P6179

1007568734

http://www.w3.org/2001/XMLSchema#string

P698

22507190

http://www.w3.org/2001/XMLSchema#string

P932

3444366

http://www.w3.org/2001/XMLSchema#string